|国家科技期刊平台
首页|期刊导航|中国普通外科杂志|肝门部胆管癌行全胰腺十二指肠联合肝脏切除、异体肝移植术1例报告并文献复习(附视频)

肝门部胆管癌行全胰腺十二指肠联合肝脏切除、异体肝移植术1例报告并文献复习(附视频)OA北大核心CSTPCD

Simultaneous total pancreaticoduodenectomy and total hepatectomy with orthotopic liver transplantation for hilar cholangiocarcinoma:a case report and literature review(with video)

中文摘要英文摘要

背景与目的:肝门部胆管癌是指发生在左右肝管、汇合部以及肝总管上段,起源于胆管上皮细胞的一种恶性肿瘤.由于肝门区结构复杂,肿瘤与门静脉、肝动脉等紧邻,故肝门部胆管癌容易出现血管、神经侵犯以及淋巴结转移;加之位置隐匿,早期缺乏特异性症状,患者往往因出现黄疸等晚期症状才会就诊.目前手术切除仍是改善预后的主要有效治疗方式,但对肝胆外科医生而言,肝门部胆管癌的外科治疗仍然是最为困难的挑战之一.笔者报告1例肝门部胆管癌侵犯胃、十二指肠、胰腺的患者施行全胰腺十二指肠联合全肝脏切除、异体肝移植术的治疗经过,以为该病的诊疗提供更多的参考依据. 方法:回顾分析中国人民解放军火箭军特色医学中心与河北医科大学第三附属医院共同完成治疗的1例肝门部胆管癌病例的临床资料,并复习相关文献,总结相关的经验教训. 结果:患者为51岁男性,有乙型肝炎病史,因腹腔积液就诊.剖腹探查(肿块为涉及肝脏、胰头、肝十二指肠韧带的一个完整无法分离的区域)与PET/CT检查(肝右叶稍低密度伴FDG代谢增高,伴门静脉主干及右支累及可能,未见明显远处转移)均考虑恶性肿瘤,但术前穿刺活检未能诊断.经讨论后对患者实施了全胰腺十二指肠联合肝脏切除与异体肝移植术(术前CT提示门静脉、肝动脉已闭塞或肿瘤侵犯,因此,术中采用肠系膜上静脉与供体门静脉吻合,用脾动脉翻转后与供体的肝固有动脉吻合).患者术后恢复顺利,术后病理示:肝门部中-高分化胆管癌,侵犯十二指肠及胃组织,侵犯胰腺,多处神经侵犯,未见明确脉管癌栓,切缘未见癌累及.术后8个月因消化道出血、感染死亡. 结论:针对肝门部胆管癌的治疗,手术切除仍是其主要治疗方式,对于不能行根治性切除的肝门部胆管癌患者,肝移植是一个可以实现R0切除,提供潜在治愈机会的选择.然而,目前联合全胰腺十二指肠切除的病例报道仍然较少,该病例的分析与总结将有助于今后更多的探索与实践.

Background and Aims:Hilar cholangiocarcinoma refer to a malignant tumor originating from the epithelial cells involving the left,right hepatic ducts,biliary confluence or the upper segment of the common hepatic duct.Due to the complex anatomy of the hilar region and its proximity to major vessels such as the portal vein and hepatic artery,this tumor is prone to vascular or neural invasion,and lymph node metastasis.Additionally,its inconspicuous location and lack of early specific symptoms often result in patients seeking medical treatment only when advanced symptoms like jaundice appear.Currently,surgical resection remains the primary effective treatment for improving prognosis.However,surgical management of hilar cholangiocarcinoma remains one of the most challenging tasks for hepatobiliary surgeons.Here,the authors report a case of hilar cholangiocarcinoma invading the stomach,duodenum,and pancreas,treated with total pancreatectomy and duodenectomy combined with total hepatectomy and orthotopic liver transplantation,aiming to provide further reference for the diagnosis and treatment of this disease. Methods:The clinical data of a case of hilar cholangiocarcinoma,collaboratively treated by the PLA Rocket Force Characteristic Medical Center and Hebei Medical University Third Hospital were retrospectively analyzed.Relevant literature was reviewed and pertinent experiences and lessons learned from this case were summarized. Results:The patient,a 51-year-old male with a history of hepatitis B,sought medical attention due to abdominal ascites.Abdominal exploration(revealing a tumor involving an inseparable region of the liver,pancreatic head,and hepatoduodenal ligament)and PET-CT scan(indicating a slightly low-density lesion with increased FDG metabolism in the right lobe of the liver,possibly involving the main portal vein and right branch,with no apparent distant metastasis)suggested a malignant tumor,but preoperative biopsy failed to provide a definitive diagnosis.After discussion,the patient underwent total pancreatectomy and duodenectomy combined with total hepatectomy and orthotopic liver transplantation(anastomosing the superior mesenteric vein with the donor portal vein and anastomosing the inverted splenic artery with the proper hepatic artery of the donor,due to preoperative CT indicating occlusion or tumor invasion of the portal vein and hepatic artery).The postoperative recovery was uneventful,and the pathology revealed moderately to well-differentiated cholangiocarcinoma of the hepatic hilar region involving the duodenum,stomach,and pancreas,with multiple neural invasions,no clear vascular tumor thrombus,and margins free of cancer.The patient died of gastrointestinal bleeding and infection 8 months after surgery. Conclusion:Surgical resection remains the primary treatment for hilar cholangiocarcinoma.For patients ineligible for radical resection,liver transplantation is an option that can achieve R0 resection,providing a potential opportunity for cure.However,there are currently still relatively few reported cases of combined total pancreaticoduodenectomy.The analysis and summary of this case will contribute to further exploration and practice in the future.

郭宇;窦剑;刘军桂;曹经琳;刘翔;金奎;雷磊;赵文利;段伟宏

中国人民解放军火箭军特色医学中心肝胆外科,北京 100088河北医科大学第三附属医院肝胆外科,河北石家庄 050051

临床医学

Klatskin肿瘤胰十二指肠切除术肝切除术肝移植

Klatskin TumorPancreaticoduodenectomyHepatectomyLiver Transplantation

《中国普通外科杂志》 2024 (001)

18-26 / 9

10.7659/j.issn.1005-6947.2024.01.003

评论